IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSNATI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.253
EU - Europa 8.457
AS - Asia 7.832
SA - Sud America 1.411
Continente sconosciuto - Info sul continente non disponibili 465
AF - Africa 193
OC - Oceania 43
Totale 35.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.798
PL - Polonia 3.415
CN - Cina 2.671
SG - Singapore 2.648
UA - Ucraina 1.299
BR - Brasile 1.165
IT - Italia 896
HK - Hong Kong 831
DE - Germania 771
VN - Vietnam 561
FI - Finlandia 452
GB - Regno Unito 407
FR - Francia 382
TR - Turchia 262
RU - Federazione Russa 239
IN - India 235
IE - Irlanda 221
CA - Canada 206
BD - Bangladesh 181
AR - Argentina 86
ID - Indonesia 81
MX - Messico 80
NL - Olanda 75
ZA - Sudafrica 66
IQ - Iraq 60
CZ - Repubblica Ceca 51
JP - Giappone 51
SE - Svezia 49
EC - Ecuador 44
AU - Australia 41
AT - Austria 38
ES - Italia 38
PK - Pakistan 35
JM - Giamaica 33
CO - Colombia 30
MA - Marocco 30
BE - Belgio 26
KE - Kenya 25
UZ - Uzbekistan 25
CL - Cile 24
VE - Venezuela 24
IR - Iran 22
SA - Arabia Saudita 21
CR - Costa Rica 20
SV - El Salvador 17
TT - Trinidad e Tobago 17
AE - Emirati Arabi Uniti 16
JO - Giordania 16
NI - Nicaragua 15
CH - Svizzera 14
CW - ???statistics.table.value.countryCode.CW??? 14
EU - Europa 14
HN - Honduras 14
IL - Israele 14
KZ - Kazakistan 14
AZ - Azerbaigian 13
EE - Estonia 13
LT - Lituania 13
PE - Perù 13
GT - Guatemala 12
NG - Nigeria 12
EG - Egitto 11
MY - Malesia 10
GP - Guadalupe 9
MU - Mauritius 9
PA - Panama 9
PY - Paraguay 9
UY - Uruguay 9
BG - Bulgaria 7
DK - Danimarca 7
DZ - Algeria 7
NP - Nepal 7
PR - Porto Rico 7
PT - Portogallo 7
TN - Tunisia 7
KR - Corea 6
LK - Sri Lanka 6
OM - Oman 6
SC - Seychelles 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
LB - Libano 5
LV - Lettonia 5
PH - Filippine 5
SN - Senegal 5
TH - Thailandia 5
NO - Norvegia 4
PS - Palestinian Territory 4
TW - Taiwan 4
AL - Albania 3
CY - Cipro 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
MD - Moldavia 3
RO - Romania 3
SI - Slovenia 3
AM - Armenia 2
AO - Angola 2
Totale 35.175
Salva come PNG Salva come JPEG
Città #
Warsaw 3.405
Fairfield 1.667
Ashburn 1.492
Woodbridge 1.276
Singapore 1.243
Jacksonville 958
San Jose 909
Houston 902
Hong Kong 828
Cambridge 713
Ann Arbor 605
Wilmington 602
Seattle 583
Beijing 571
Chandler 503
Council Bluffs 495
The Dalles 460
Princeton 398
Nanjing 348
New York 327
Dallas 315
Los Angeles 259
Helsinki 244
Dublin 215
Lauterbourg 204
Columbus 201
Istanbul 186
Dearborn 154
Brescia 151
Ho Chi Minh City 151
Santa Clara 132
Milan 125
Nanchang 125
Dong Ket 122
São Paulo 116
Munich 114
Buffalo 101
San Francisco 99
Moscow 98
Hanoi 97
Chicago 92
San Diego 90
Des Moines 89
Shenyang 84
Jinan 83
Changsha 80
Phoenix 80
Boardman 78
Hebei 74
Redondo Beach 70
Tianjin 68
Jiaxing 65
Lancaster 65
London 64
Shanghai 63
Orem 59
Brooklyn 57
Atlanta 54
North Bergen 54
Hangzhou 53
Rome 49
Toronto 48
Jakarta 46
Kunming 46
Montreal 44
Tokyo 44
Verona 40
Johannesburg 36
Augusta 35
Guangzhou 35
Rio de Janeiro 34
San Mateo 32
Chennai 31
Denver 31
Manchester 31
Porto Alegre 31
Belo Horizonte 30
Frankfurt am Main 29
Zhengzhou 29
Nuremberg 28
Turku 28
Brno 27
Haikou 27
Lanzhou 27
Mexico City 26
Ningbo 26
Curitiba 25
Leawood 25
Amsterdam 24
Kocaeli 24
Brussels 23
Norwalk 23
Parma 23
Brasília 22
Charlotte 22
Poplar 22
Mumbai 21
Nairobi 21
Olomouc 21
Tashkent 21
Totale 24.123
Salva come PNG Salva come JPEG
Nome #
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 419
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 398
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 375
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 333
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 329
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 328
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 326
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 318
Biological role of immunoglobulin Free light chains interactomes 317
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 304
Different effects of mucosal, beef lung, and chemically modified heparin on selected biological properties of basic fibroblast growth factor 301
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures. 296
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 295
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 295
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 294
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 292
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 290
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 281
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 274
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 272
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 269
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 266
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 262
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 260
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 259
The FGF2-binding domain of thrombospondin-1: functional characterization and exploitation to design antiangiogenic compounds 257
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 256
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 252
Chemoselective surface immbolization of proteins through a cleavable peptide 250
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 244
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 237
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 236
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 234
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 232
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 229
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 220
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 220
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 215
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 213
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 209
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 208
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 207
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 204
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 202
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 202
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 199
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 198
The colloidal side of cell communication. 196
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 195
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 194
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 193
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 190
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 189
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 184
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 184
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 183
Sialic acid as a target for the development of novel antiangiogenic strategies 181
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 177
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 175
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 175
Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona "variable" 174
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 173
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 170
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 169
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 169
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 169
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 168
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 164
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 164
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 164
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 164
Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form. 163
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 162
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity 161
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 161
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 159
Multiple interactions of HIV-1 Tat protein with size-defined heparin oligosaccharides 158
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 156
Biochemical bases of the interaction of the human basic fibroblast growth factor with glycosaminoglycans: new insights from trypsin digestion studies 156
Fibroblast growth factor-2 in angiogenesis 155
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 155
Plasmonic exosomes for enhanced monitoring of monoclonal gammopathies 154
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 153
A monoclonal antibody to the NH2-terminal region of HuIFN inhibits the antiproliferative activity of the lymphokine without affecting its internalization 153
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 151
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 149
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. 148
Dendritic cell-endothelial cell cross-talk in angiogenesis. 148
Heparin derivatives as angiogenesis inhibitors 146
Liver DNA damage by chemical carcinogens: role of thyroid hormones 146
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 146
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 145
Multispot, label-free biodetection at a phantom plastic-water interface. 145
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 144
Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans 144
Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region. 144
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 141
Angiogenic phenotype induced by basic fibroblast growth factor transfection in brain microvascular endothelial cells: an in vitro autocrine model of angiogenesis in brain tumors 141
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein 140
Targeting fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis 140
Totale 21.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.427
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.239 0 0 0 43 24 69 123 119 84 235 141 401
2022/20231.409 219 59 56 93 106 382 9 149 198 18 48 72
2023/20241.549 93 30 137 68 67 235 52 69 403 49 40 306
2024/20253.988 47 23 18 493 356 286 279 125 350 461 948 602
2025/20268.982 824 1.167 829 1.315 805 602 1.301 317 579 736 268 239
2026/20272.598 391 559 678 970 0 0 0 0 0 0 0 0
Totale 35.654